Oligonucleotide Synthesis Market Size, Share, Emerging Trends, Growth, and Opportunities 2034
Oligonucleotide Synthesis Market Size, Share, Emerging Trends, Growth, and Opportunities 2034
The global oligonucleotide synthesis market growth in 2026 is expanding rapidly as pharmaceutical companies, biotechnology firms, and research institutions increasingly use synthetic DNA and RNA sequences for drug development, molecular diagnostics, and genomic research. According to Fortune Business Insights, the global oligonucleotide synthesis market size was valued at USD 10.78 billion in 2025. The market is projected to grow from USD 12.81 billion in 2026 to USD 50.84 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 18.8% during the forecast period. North America dominated the market with a 40% revenue share in 2025.
Oligonucleotide synthesis involves producing short, precisely defined DNA or RNA sequences for use in scientific research and commercial applications. These sequences are essential components in polymerase chain reaction (PCR), DNA sequencing, gene editing, molecular diagnostics, and nucleic acid-based therapeutics. Growing investment in genomics and precision medicine is increasing demand for customized oligonucleotides with high purity and sequence accuracy.
Key companies operating in the global oligonucleotide synthesis market include:
Agilent Technologies
ATDBio Ltd.
Eurofins Genomics
Eurogentec
GenScript
Integrated DNA Technologies Inc.
LGC Biosearch Technologies
Merck KGaA
Nitto Denko Avecia
Thermo Fisher Scientific
Others
These companies support the market through custom synthesis services, research products, manufacturing capabilities, and specialized oligonucleotide solutions. Competition increasingly depends on product quality, turnaround times, production capacity, and the ability to supply customized sequences for research and therapeutic applications.
Increasing demand for nucleic acid-based therapeutics: Pharmaceutical and biotechnology companies are developing treatments that use oligonucleotides, including antisense oligonucleotides and small interfering RNA (siRNA). These approaches are expanding the need for reliable synthesis services and high-quality materials suitable for research, clinical development, and commercial production.
Expansion of genomic research and molecular diagnostics: Oligonucleotides are widely used as primers and probes in PCR, DNA sequencing, and hybridization-based testing. Increasing research activity in genomics, genetic mutations, and molecular biology is supporting demand from research institutes and diagnostic laboratories.
Automation and improved synthesis technologies: Automated synthesis equipment and advanced purification techniques can improve throughput, reproducibility, and production consistency. These technologies are important for suppliers serving customers that require customized sequences or larger quantities for advanced research and therapeutic development.
Complex production and quality requirements: Producing high-purity oligonucleotides at scale involves specialized synthesis, purification, and analytical procedures. Maintaining batch consistency and controlling impurities can increase operating costs and require substantial investment in equipment, facilities, and technical expertise.
Supply and scalability challenges: Custom chemical modifications and specialized reagents can complicate production schedules. Manufacturers must balance increasing customer demand with quality requirements, cost efficiency, and reliable delivery, particularly when supplying material for clinical and commercial applications.
The market includes established life sciences suppliers and specialized synthesis providers. Agilent Technologies, Eurofins Genomics, GenScript, Integrated DNA Technologies Inc., Merck KGaA, and Thermo Fisher Scientific are among the companies identified in the report.
Competition is influenced by synthesis accuracy, purity, production scale, customization capabilities, and customer support. Pharmaceutical and biotechnology customers increasingly require suppliers that can accommodate specialized modifications and deliver consistent materials for research and drug development.
Companies are investing in manufacturing capabilities, automated workflows, and advanced purification processes to address these requirements. Outsourcing also creates opportunities for specialized providers that can supply customized oligonucleotides without requiring customers to maintain their own synthesis infrastructure.
The global oligonucleotide synthesis market is segmented by
by Products (Drugs, Probes, Linkers, Adapters, Reagents, Others)
By Application (DNA Sequencing and Amplification (PCR), Detecting Complementary DNA or RNA Via Hybridization, Synthesis of Artificial Genes, Genetic Mutations, Others)
By End User (Research Institutes, Diagnostic Laboratories, Pharmaceuticals Industries, Biotechnology Companies)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/oligonucleotide-synthesis-market-101020
North America: North America dominated the market with a 40% revenue share in 2025. Strong pharmaceutical research, biotechnology investment, and demand for nucleic acid-based technologies support the region's leading position.
Europe: Europe accounted for approximately 28% of the market. Research institutions, pharmaceutical development, and biotechnology activities contribute to regional demand for customized oligonucleotides.
Asia Pacific: Asia Pacific held approximately 22% of the market. Investment in genomics, biotechnology, healthcare infrastructure, and pharmaceutical research supports its growing role in oligonucleotide synthesis.
Demand for high-purity products, customized sequences, and scalable production is expected to influence future competition. Automation and advanced purification technologies will remain important for improving consistency and throughput. Companies that strengthen their synthesis capabilities and meet the quality requirements of pharmaceutical, biotechnology, and research customers will be well positioned to participate in the market's continued expansion.
Explore Japan’s Market Opportunities - Latest -Oligonucleotide Synthesis Market- Insights